Our Work
Santé publique France’s efforts to combat and prevent antibiotic resistance are guided by national objectives outlined in:
- the 2022–2025 National Strategy for the Prevention of Infections and Antibiotic Resistance (published in February 2022 and extended through 2027);
- the interministerial roadmap for controlling antibiotic resistance (last updated in 2024).
To help preserve the effectiveness of antibiotics, Santé publique France carries out or coordinates initiatives at the national level in three areas:
- epidemiological surveillance of antibiotic resistance and antibiotic use;
- management of reports of healthcare-associated infections caused by emerging highly resistant bacteria (BHRe) in collaboration with the CPias and the National Reference Center (CNR) for Antibiotic Resistance;
- initiatives to prevent antibiotic resistance, including public communication on the subject that is accessible to as many people as possible.
The resources deployed by Santé publique France and its partners have equipped France with the capacity to:
- produce annual surveillance data on bacterial antibiotic resistance and antibiotic use across the three healthcare sectors: healthcare facilities, medical-social facilities (particularly facilities for dependent elderly individuals), and outpatient care, at the national and regional levels, as well as certain data at the departmental and EPCI levels;
- rapidly detect the emergence of new forms of resistance, and monitor and control an outbreak;
- promote actions to prevent antibiotic resistance through a One Health approach, taking into account the links between humans, animals, and their environment.
Santé publique France also coordinates France’s participation in European surveillance of antibiotic resistance.